Results 201 to 210 of about 626,048 (303)

Editorial: Insights in intensive care medicine and anesthesiology: 2022. [PDF]

Front Med (Lausanne)
Kaynar AM.
europepmc   +1 more source

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

Arthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

Management of severe acute encephalopathy in the ICU: an expert consensus statement from the french society of intensive care medicine. [PDF]

Ann Intensive Care
Sonneville R, Azabou E, Bailly P, Benghanem S, De Almeida Cardoso G, Claquin P, Cortier D, Gaudemer A, Hermann B, Jaquet P, Lambrecq V, Legouy C, Legriel S, Rambaud T, Rohaut B, Sarton B, Silva S, Sharshar T, Taccone FS, Vodovar D, Weiss N, Cerf C.   +21 more
europepmc   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

Experience of Early Postgraduate Transition to Intensive Care Medicine: A Phenomenological Study. [PDF]

Cureus
Enright D, Colgan R, O'Connor E.
europepmc   +1 more source

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

Arthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah, Alexis Castellanos, Yen Chen, John Piette, Amy Bucher, Susan Murphy   +5 more
wiley   +1 more source

Artificial intelligence to advance acute and intensive care medicine. [PDF]

Curr Opin Crit Care
Biesheuvel LA, Dongelmans DA, Elbers PWG.   +2 more
europepmc   +1 more source

ARTIFICIAL INTELLIGENCE IN EMERGENCY AND INTENSIVE CARE MEDICINE - BENEFIT OR RISK?

Tornike Zedelashvili
openalex   +2 more sources

Development of a Personalized Visualization and Analysis Tool to Improve Clinical Care in Complex Multisystem Diseases With Application to Scleroderma

Arthritis Care &Research, EarlyView.
Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim, John Scott, Lauren Fisher, Lauren N. Smith, Willie Stewart, Adrianne Woods, Rob Smithwright, Diane Koher, Parastoo Aslanbeik, Aalok B. Shah, Brad Tibbils, Samantha I. Pitts, Ayse P. Gurses, Yushi Yang, Ana‐Maria Orbai, Antony Rosen, Laura K. Hummers, Scott L. Zeger, Ami A. Shah   +18 more
wiley   +1 more source

Job Satisfaction Among First-Generation Migrant Physicians in Anesthesiology and Intensive Care Medicine in Germany. [PDF]

Healthcare (Basel)
Elnahas M, Hübner J, Lang PM, Ahmadi E.
europepmc   +1 more source